HTA36 Value of Real-World Evidence for Treatments for Ultra Orphan or Rare Diseases: Lessons and Insights From Review of NICE Highly Specialized Technology Assessment Reports (2016-2022)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1496
https://www.valueinhealthjournal.com/article/S1098-3015(22)03701-9/fulltext
Title :
HTA36 Value of Real-World Evidence for Treatments for Ultra Orphan or Rare Diseases: Lessons and Insights From Review of NICE Highly Specialized Technology Assessment Reports (2016-2022)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03701-9&doi=10.1016/j.jval.2022.09.1496
First page :
Section Title :
Open access? :
No
Section Order :
11048